ε4 allele
Recently Published Documents


TOTAL DOCUMENTS

404
(FIVE YEARS 129)

H-INDEX

42
(FIVE YEARS 5)

2022 ◽  
pp. 0271678X2110690
Author(s):  
Charles E Seaks ◽  
Erica M Weekman ◽  
Tiffany L Sudduth ◽  
Kevin Xie ◽  
Brandi Wasek ◽  
...  

Vascular contributions to cognitive impairment and dementia (VCID) are the second leading cause of dementia behind Alzheimer’s disease. Apolipoprotein E (ApoE) is a lipid transporting lipoprotein found within the brain and periphery. The APOE ε4 allele is the strongest genetic risk factor for late onset Alzheimer’s disease and is a risk factor for VCID. Our lab has previously utilized a dietary model of hyperhomocysteinemia (HHcy) to induce VCID pathology and cognitive deficits in mice. This diet induces perivascular inflammation through cumulative oxidative damage leading to glial mediated inflammation and blood brain barrier breakdown. Here, we examine the impact of ApoE ε4 compared to ε3 alleles on the progression of VCID pathology and inflammation in our dietary model of HHcy. We report a significant resistance to HHcy induction in ε4 mice, accompanied by a number of related differences related to homocysteine (Hcy) metabolism and methylation cycle, or 1-C, metabolites. There were also significant differences in inflammatory profiles between ε3 and ε4 mice, as well as significant reduction in Serpina3n, a serine protease inhibitor associated with ApoE ε4, expression in ε4 HHcy mice relative to ε4 controls. Finally, we find evidence of pervasive sex differences within both genotypes in response to HHcy induction.


Cells ◽  
2021 ◽  
Vol 11 (1) ◽  
pp. 29
Author(s):  
Chun Xu ◽  
Debra Garcia ◽  
Yongke Lu ◽  
Kaysie Ozuna ◽  
Donald Adjeroh ◽  
...  

Angiotensin-converting enzyme-1 (ACE1) and apolipoproteins (APOs) may play important roles in the development of Alzheimer’s disease (AD) and cardiovascular diseases (CVDs). This study aimed to examine the associations of AD, CVD, and endocrine-metabolic diseases (EMDs) with the levels of ACE1 and 9 APO proteins (ApoAI, ApoAII, ApoAIV, ApoB, ApoCI, ApoCIII, ApoD, ApoE, and ApoH). Non-Hispanic white individuals including 109 patients with AD, 356 mild cognitive impairment (MCI), 373 CVD, 198 EMD and controls were selected from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset. Multivariable general linear model (GLM) was used to examine the associations. ApoE ε4 allele was associated with AD, as well as ApoAIV, ApoB and ApoE proteins, but not associated with CVD and EMD. Both AD and CVD were associated with levels of ACE1, ApoB, and ApoH proteins. AD, MCI and EMD were associated with levels of ACE1, ApoAII, and ApoE proteins. This is the first study to report associations of ACE1 and several APO proteins with AD, MCI, CVD and EMD, respectively, including upregulated and downregulated protein levels. In conclusion, as specific or shared biomarkers, the levels of ACE1 and APO proteins are implicated for AD, CVD, EMD and ApoE ε4 allele. Further studies are required for validation to establish reliable biomarkers for these health conditions.


Author(s):  
Jennifer A Margrett ◽  
Thomas Schofield ◽  
Peter Martin ◽  
Leonard W Poon ◽  
Kamal Masaki ◽  
...  

Abstract To investigate inter-individual differences in cognitive terminal decline and identify determinants including functional, health, and genetic risk and protective factors, data from the Honolulu Heart Program/Honolulu-Asia Aging Study, a prospective cohort study of Japanese American men, were analyzed. The sample was recruited in 1965-68 (ages 45-68 years). Longitudinal performance of cognitive abilities and mortality status were assessed from Exam 4 (1991-1994) through June 2014. Latent class analysis revealed two groups: maintainers retained relatively high levels of cognitive functioning until death and decliners demonstrated significant cognitive waning several years prior to death. Maintainers were more likely to have greater education, diagnosed coronary heart disease, and presence of the apolipoprotein E (APOE) ε2 allele and FOXO3 G allele (SNP rs2802292). Decliners were more likely to be older and have prior stroke, Parkinson’s disease, dementia, and greater depressive symptoms at Exam 4, and the APOE ε4 allele. Findings support terminal decline using distance to death as the basis for modeling change. Significant differences were observed between maintainers and decliners 15 years prior to death, a finding much earlier compared to the majority of previous investigations.


2021 ◽  
Vol 12 ◽  
Author(s):  
Jianxin Zhou ◽  
Li Jiang ◽  
Sangui Yuan ◽  
Jiashang Huang ◽  
Quanhong Shi ◽  
...  

Objective: This study investigates the correlation between Apolipoprotein E gene (APOE) polymorphism and the incidence and delayed resolution of hemifacial spasms.Methods: The APOE genotypes of 151 patients with hemifacial spasm and 73 control cases were determined by cleaved amplification polymorphism sequence-tagged sites. The distribution of three APOE alleles (ε2, ε3, and ε4) in two groups and the delayed resolution rate in 6 genotypes were calculated and statistically analyzed.Results: The proportion of patients with APOE ε3/ε4 genotype in the hemifacial spasm group (25.17%) was significantly higher than that in the control group (12.33%) (P = 0.027). In terms of allele frequency, the proportion of the APOE ε4 allele in the hemifacial spasm group (15.56%) was significantly higher than that in the control group (6.85%) (P = 0.009). Meanwhile, the proportion of APOE ε4 allele carriers in the hemifacial spasm group (29.80%) was significantly higher than that in the control group (13.7%) (P = 0.009). Logistic regression analysis showed that the ε4 allele significantly increased the incidence of hemifacial spasm (OR 2.675, 95%CI 1.260-5.678, P = 0.010). Among the 32 patients with a delayed resolution, the ε3/ε3 and ε3/ε4 had the highest proportion in 6 genotypes. The delayed resolution rate of APOE ε3/ε4 (34.21%) was significantly higher than APOE ε3/ε3 (17.78%) (P < 0.05). The delayed resolution rate of APOE ε4 carriers was the highest (33.33%) in the 3 allele carriers, but there was no significant difference among the 3 allele carriers (P = 0.065).Conclusion: The polymorphism of APOE is relevant to the incidence rate of hemifacial spasms. APOE ε4 allele increases the incidence of hemifacial spasm. The APOE ε4 allele may promote the occurrence of delayed resolution.


Genes ◽  
2021 ◽  
Vol 12 (12) ◽  
pp. 1954
Author(s):  
Ove Almkvist ◽  
Caroline Graff

Mounting evidence shows that the APOE ε4 allele interferes with cognition in sporadic Alzheimer’s disease. Less is known about APOE in autosomal-dominant Alzheimer’s disease (adAD). The present study explored the effects on cognition associated with the gene–gene interactions between the APOE gene and the APP and PSEN1 genes in adAD. This study includes mutation carriers (MC) and non-carriers (NC) from adAD families with mutations in APP (n = 28 and n = 25; MC and NC, respectively) and PSEN1 (n = 12 and n = 15; MC and NC, respectively) that represent the complete spectrum of disease: AD dementia (n = 8) and mild cognitive impairment (MCI, n = 15 and presymptomatic AD, n = 17). NC represented unimpaired normal aging. There was no significant difference in the distribution of APOE ε4 (absence vs. presence) between the APP vs. PSEN1 adAD genes and mutation status (MC vs. NC). However, episodic memory was significantly affected by the interaction between APOE and the APP vs. PSEN1 genes in MC. This was explained by favorable performance in the absence of APOE ε4 in PSEN1 compared to APP MC. Similar trends were seen in other cognitive functions. No significant associations between APOE ε4 and cognitive performance were obtained in NC. In conclusion, cognitive effects of APOE–adAD gene interaction were differentiated between the PSEN1 and APP mutation carriers, indicating epistasis.


2021 ◽  
pp. 113700
Author(s):  
Renata Valle Pedroso ◽  
Francisco José Fraga ◽  
Carla Manuela Crispim Nascimento ◽  
Henrique Pott-Junior ◽  
Márcia Regina Cominetti

2021 ◽  
Vol 17 (S6) ◽  
Author(s):  
Anna Brugulat‐Serrat ◽  
Elena Tsoy ◽  
Marta Milà‐Alomà ◽  
Gonzalo Sánchez‐Benavides ◽  
Rachel F. Buckley ◽  
...  

2021 ◽  
Author(s):  
Wenbing Ma ◽  
Liting Zhang ◽  
Shuang Yang ◽  
Suya Zhang ◽  
Haiyan Dong ◽  
...  

Abstract Background: The apolipoprotein E (ApoE) genetic variation may be involved in the development of Cerebral Infarction (CI). Serum lipid levels are known risk factors for CI, but the effect of the ApoE gene polymorphism on lipid metabolism remains unclear. This retrospective cohort study aimed to determine the role of ApoE genotypes in CI risk and the relationships between ApoE gene polymorphism and serum lipid levels among the population of northwest China.patients and methods: 517 CI patients and 517 non-CI controls were enrolled in the study. Polymerase chain reaction and hybridization were used to test the ApoE gene polymorphisms.results: Patients with CI had a significantly higher frequency of ε3/ε4 genotype (OR =2.057, 95% CI = 1.477–2.864, P<0.001) and ε4 allele (OR =1.818, 95% CI = 1.364–2.424, P<0.001) than control participants. When stratifying by age and sex, it was found that statistically significant differences in the distribution and frequencies of the ε3/ε4 genotype(OR =3.067, 95% CI = 1.675–5.614, P<0.001 in age ≤60 years; OR =1.735, 95% CI = 1.156–2.604, P=0.008 in age >60 years and OR =2.206, 95% CI = 1.474–3.301, P<0.001 in males) and ε4 allele (OR =1.709, 95% CI = 1.201–2.432, P=0.001) in males and ε4 allele (OR =2.072, 95% CI = 1.281–3.353, P=0.003 in age ≤60 years; OR =1.704, 95% CI = 1.189–2.444, P=0.003 in age>60 years; OR =1.709, 95% CI = 1.201–2.432, P=0.001 in males and OR =2.046, 95% CI = 1.246–3.361, P=0.004 in females ) were observed between patients and controls. ε4 carriers had significantly lower ApoE level and higher low-density lipoprotein cholesterol (LDL-C), ApoB and ApoB/ApoA-I levels than ε2 carriers in both two groups. Additionally, control participants with ε4 carriers had significantly higher levels of lipoprotein and lower total cholesterol (TC) levels than ε2 carriers, CI patients with ε4 carriers had significantly lower level of ApoA-I than ε2 carriers. After adjusting for other established risk factors, drinking, hypertension, lipoprotein, triglycerides (TG) and ε4 allele were significant independent risk factor for CAD. ε4 allele presence was associated with a nearly two-fold higher CI risk.Conclusions: This study provides evidence that ε4 allele, drinking, hypertension, lipoprotein and TG levels are independent risk factor for CI among patients in Northwest China. Also, these data might be clinically useful in allowing for more individualized preventive and therapeutic strategies.


Genes ◽  
2021 ◽  
Vol 12 (11) ◽  
pp. 1768
Author(s):  
Stephanie Lozano ◽  
Victoria Padilla ◽  
Manuel Lee Avila ◽  
Mario Gil ◽  
Gladys Maestre ◽  
...  

Genetic variants in the apolipoprotein E (APOE) gene are associated with lipid metabolism and lipid-related traits in the non-Hispanic population. There have been limited studies regarding the association between the APOE gene and hypercholesterolemia in the Hispanic population; therefore, our aim for this study is to examine the APOE gene’s associations with cholesterol level and its related phenotypes. The APOE gene consists of three different alleles, ε2, ε3, and ε4, with ε4 being associated with dementia and cardiovascular diseases. A total of 1,382 subjects were collected from the Texas Alzheimer’s Research and Care Consortium (TARCC, N = 1320) and the Initial Study of Longevity and Dementia from the Rio Grande Valley (ISLD-RGV, N = 62). Questionnaires on demographics, medical history, and blood/saliva samples were collected and APOE genotypes were performed. We observed allele frequencies of the APOE ε3 (96.7%), ε4 (22.6%) and ε2 (6.8%) alleles, respectively. Multivariable logistic regression revealed a significant association between the APOE ε4 allele and hypercholesteremia (p = 1.8 × 10−4) in our studied Hispanic population. We prove for the first time, that the APOE ε4 allele increases the risk for hypercholesterol in Hispanics. Further research is needed to confirm and supports our current findings.


Sign in / Sign up

Export Citation Format

Share Document